https://www.selleckchem.com/pr....oducts/oxidopamine-h
The secondary outcomes include reduced stunting among children and the prevalence of maternal depression. We will also assess the cost-effectiveness of the integrated intervention, and will further explore the intervention's acceptability and feasibility. At the time of submission, the study was at the stage of endpoint assessment. The data analysis started in December 2020, and the results are expected to be published after the first quarter of 2021. This study will address the burden of childhood developmental delays
Like
Comment
Share
